Diabetes

Heart disease is still the leading cause of death for men in Tennessee and cancer deaths continue to move further away from the Centers for Disease Control and Prevention’s Healthy People 2020 goal, according to the 2012 Tennessee Men’s Health Report Card. Read More

Vanderbilt researchers have developed a biomarker for beta cells that could make it easier to detect diabetes earlier. Read More

On May 4, the Community Research Partners meeting will convene, focusing on the importance of health literacy and health communication in patient health, with a particular focus on the role of health literacy in diabetes and obesity. The presentation will include the discussion of a current… Read More

Targeting diabetes that develops after a stem cell transplant may help moderate graft-vs.-host disease, an adverse effect of the procedure, and improve outcomes. Read More

Vanderbilt University is already doing genetic analyses of patients to help in developing a shortlist of effective drugs, says Dr. William Schaffner, chairman of the department of preventive medicine at its medical school. Read More

Vanderbilt Heart recently used a newly approved medical device to open narrowed coronary arteries, even in heart disease patients who also have diabetes. Read More

Shelagh Mulvaney (Steve Green/Vanderbilt) Using social media to communicate and educate about diabetes is the topic of a lunchtime lecture on March 23. Shelagh Mulvaney, assistant professor of nursing, biomedical informatics and pediatrics at Vanderbilt, will discuss “The Rules of Engagement: Using Social Technologies to Enhance Diabetes… Read More

Studies offer new insights into how obesity impairs the function of HDL, the “good” cholesterol. Read More

A new study finds long-lasting reversal of diabetes is possible without insulin through transplantation of brown fat tissue. Read More

A strain of mutant mice provide a novel model for studying glucose intolerance and gestational diabetes during pregnancy and suggest that certain molecules may be useful for therapeutic applications. Read More

Research participant Loren Kirkpatrick, right, has worked with Janie Lipps, MSN, and Vanderbilt’s Diabetes Control and Complications Trial since its inception in 1983. (Daniel Dubois / Vanderbilt) Loren Kirkpatrick has been enrolled in the Diabetes Control and Complications Trial (DCCT) at Vanderbilt’s Diabetes Center for nearly half… Read More

(iStock) Fatty liver, a reversible condition of fat accumulation in liver cells, can result from excessive alcohol consumption, obesity, type 2 diabetes, or metabolic disorders. Exercise can reverse this process, but the mechanisms underlying this effect are not clear. Because exercise is known to stimulate the action of glucagon (a… Read More

A growth factor may help grow transplantation-quality pancreas cells for treating diabetes. Read More

The new Center for Diabetes Translation Research will translate scientific breakthroughs into practices that can be applied in the doctor’s office and the patient’s home. Read More

A new study indicates that patients with high-grade glioma brain tumors who have preexisting type 2 diabetes or obesity have poorer outcomes, and is the first to use the Vanderbilt Brain Tumor Center Clinical Database to report a novel clinical finding. Read More

Vanderbilt leads the nation in a breakthrough drug study that may prevent type-1 diabetes! Plus, how studying the brain could impact criminal law. And a special tribute on the anniversary of 9/11. [vucastblurb]… Read More

Video: Watch this story about a breakthrough drug study that may prevent type-1 diabetes. Read More

Vanderbilt will field a walking team for the Walk to Cure Diabetes on Saturday, Sept. 24, at Bicentennial Mall. There will be breakfast, lunch, kids zone, live entertainment and more at the event. Click here to join Team Vanderbilt, or stop by the Vanderbilt Diabetes Center table in… Read More

New research into changes in the brains of obese patients and others with substance abuse issues indicate doctors should be more understanding when treating these patients. Read More

Antioxidant genes may be good targets for treating a stomach disorder that affects up to 40 percent of patients with diabetes. Read More